(Report ID: 45069) Drug interactions analysis of: Duragesic-100, Tylenol (caplet), Insulin, AspirinMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,648 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 6 relevant incidents-Insulin-A_general_trend_45069.png)
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 45069 | Feb, 14, 2006 | 63 | Female |
List of drugs the patient takes:
| Drug |
Duragesic-100 |
Tylenol (caplet) |
Insulin |
Aspirin |
List of drug interactions, adverse side effects / events the patient has:
| Name |
Cerebrovascular Accident |
Hallucination |
Hallucination, Visual |
Irritability |
Tremor |
Results from eHealthMe: 6 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Cerebrovascular Accident | 1 (16.67%) |
Hallucination | 1 (16.67%) |
Hallucination, Visual | 1 (16.67%) |
Irritability | 1 (16.67%) |
Tremor | 1 (16.67%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:
3) Top co-used drugs drugs reported for the past 12 months:
4) Top drug interactions, adverse side effects reported of all time:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Kidney Transplant Rejection | 3 (50.00%) |
2 | Post Procedural Complication | 2 (33.33%) |
3 | Acute Respiratory Distress Syndrome | 2 (33.33%) |
4 | Confusional State | 2 (33.33%) |
5 | Mental Status Changes | 2 (33.33%) |
6 | Respiratory Failure | 2 (33.33%) |
7 | Sepsis | 2 (33.33%) |
8 | Pain In Extremity | 2 (33.33%) |
9 | Complications Of Transplanted Kidney | 1 (16.67%) |
10 | Blood Pressure Diastolic Decreased | 1 (16.67%) |
5) Top co-used drugs drugs reported of all time:
| Name | Count |
1 | Prednisone | 6 |
2 | Cellcept | 4 |
3 | Nystatin | 3 |
4 | Lasix | 3 |
5 | Propofol | 3 |
6 | Pepcid | 3 |
7 | Diltiazem | 3 |
8 | Heparin | 2 |
9 | Rifampin | 2 |
10 | Diprivan | 2 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Zyrtec (Mcneil Consumer) - 10MG for Allergies (Nov, 21, 2008)
|
Allopurinol (Apotex Inc) - 300MG for Gout - Chronic (Nov, 21, 2008)
|
Nadolol for Anxiety (Nov, 21, 2008)
|
Depakote (Abbott) - EQ 500MG VALPROIC... for Epilepsy (Nov, 21, 2008)
|
Cymbalta (Lilly) - EQ 20MG BASE for Depression (Nov, 21, 2008)
|
Vicodin Es (Abbott) - 750MG;7.5MG for Toothaches (Nov, 21, 2008)
|
Vicodin Es (Abbott) - 750MG;7.5MG for Toothaches (Nov, 21, 2008)
|
Lyrica (Pfizer) - 100MG for Back Pain - Low (Nov, 21, 2008)
|
Sodium Bicarbonate (Hospira) - 0.9MEQ... for Heartburn (Nov, 21, 2008)
|
Side effects comparison of Lipitor (Pfizer) - EQ 20MG BASE (Nov, 21, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|